Researchers have released TripletDGC, a publicly available resource that links nearly 10,000 disease-associated genes to the specific cell types they most strongly affect, filling a critical gap in our understanding of how genetic risk drives disease at the cellular level.

“By linking each disease gene to its most affected cell type, we can finally see the cellular battlefields where genetic risk plays out,” says Prof. Bingbo Wang. “This clarity will fast-track the design of therapies that hit the right cellular targets, cutting years off drug development and bringing precision medicine into sharper focus.”

Overview of the TripletDGC framework for assessing critical cell types of disease genes

(a) the Triplet association between a disease, a disease gene and a cell type; (b) a toy UMAP visualization showing single-cell genomics (scRNA-seq) data; (c) an illustration of cis-eQTL showing human genetics(eQTL) data we used; (d) the framework of assessing critical cell types for the disease gene; (e) specificity matrix, visualization of cell type specificity index (–log(p-value)) for each gene in the disease D; (f) the TripletDGC dataset structure; (g) statistical analyses of TripletDGC dataset and original data, the means of different counts are highlighted with red dashed lines; (h) a bar chart visualizing the critical cell types associated with selected asthma disease genes, based on their specificity index (–log(p-value)). Stars indicate triplets with a specificity index greater than 5

Pinpointing disease gene impact in specific cell types to accelerate targeted therapies and precision medicine

Knowing which cells carry the impact of disease genes can speed the development of targeted therapies, guide precision-medicine strategies, and help policymakers prioritize research funding. By pinpointing the exact cell types where genetic risk takes hold, TripletDGC offers a roadmap for scientists and industry to focus on the most relevant cellular targets.

Mapping 9,905 disease genes across 93 complex diseases reveals 54,240 gene–cell links for drug target discovery

The study revealed several clear insights into how disease genes map onto specific cell types:

• TripletDGC maps 9,905 disease genes across 93 complex diseases to their critical cell types, generating 54,240 gene–disease–cell links.
• On average, each disease gene influences about 1.4 cell types, highlighting focused cellular roles for most genes.
• Each complex disease is connected to over 11 distinct cell types via roughly 56 different genes, underscoring disease complexity.
• Individual cell types are linked to an average of 8.5 diseases, suggesting shared cellular pathways may underpin disease comorbidity.
• In a case study on asthma, key genes such as HLA-DR family members and XCL1 were confirmed to act in dendritic cells and T cells, cells known to drive asthma inflammation.

Harnessing over 480,000 single-cell RNA-seq profiles across 475 cell types unveils marker-enrichment scoring of disease genes

Researchers combined high-resolution single-cell RNA sequencing data from nearly half a million cells (475 cell types) with genetic maps that show how DNA variants alter gene activity. For each disease gene, they collected nearby genetic markers, identified which genes those markers regulated, and then tested which cell-type marker genes were enriched among those targets. Statistical enrichment and a simple scoring method highlighted the cell types most strongly controlled by each disease gene.

Open-source toolkit on GitHub lays the groundwork for precise drug target prediction

TripletDGC is now available on GitHub. By delivering clear, gene-level links to cell types, it lays the groundwork for more precise drug target prediction and helps researchers uncover new disease genes. It opens the door to more profound insights into disease mechanisms and more effective, cell-focused therapies.

Source – Newswise